SearchDictionaryMobileLogin

E William St Clair Selected Research

Wegener Granulomatosis (Wegener's Granulomatosis)

05/2008Effects of glucocorticoids on weight change during the treatment of Wegener's granulomatosis.
12/2007The frequency of anticardiolipin antibodies and genetic mutations associated with hypercoagulability among patients with Wegener's granulomatosis with and without history of a thrombotic event.
11/2007Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis.
07/2007ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis.
05/2007Antiendothelial cell antibodies in patients with Wegener's granulomatosis: prevalence and correlation with disease activity and manifestations.
05/2006Solid malignancies among patients in the Wegener's Granulomatosis Etanercept Trial.
07/2005Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET).

Articles by Research Topic

Disease

7Wegener Granulomatosis (Wegener's Granulomatosis)
05/2008 - 07/2005
7Rheumatoid Arthritis
09/2006 - 11/2004
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2004 - 07/2002
1Thrombophilia
12/2007

Drug/Important Bio-Agent (IBA)

5infliximab (Remicade)FDA Link
09/2006 - 11/2004
3Methotrexate (Mexate)FDA LinkGeneric
09/2006 - 11/2004
2Anticardiolipin AntibodiesIBA
12/2007 - 09/2006
2Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
11/2007 - 07/2007
2TNFR-Fc fusion protein (etanercept)FDA Link
05/2006 - 07/2005
1GlucocorticoidsIBA
05/2008
1AntibodiesIBA
05/2007
1Immunoglobulin M (IgM)IBA
09/2006
1Immunoglobulin G (IgG)IBA
09/2006
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2006
1TransferasesIBA
01/2004
1Silicon Dioxide (Sand)IBA
07/2002

Therapy/Procedure

1Therapeutics
02/2006